AMBA

Ambarella has executed a genuine fundamental inflection. FY2026 revenue of $391M (+37.2% YoY) not only reverses the FY2024 collapse to $226M but pushes through the prior FY2023 peak of $338M, validating the company's repositioning around low-power edge/physical-AI SoCs described in the 10-K. Quality of the franchise is solid: gross margin held at 59.2%, the balance sheet carries $191M cash against just 0.34x liabilities/equity with negligible debt, and — most importantly — operating cash flow swung to a positive $73.5M, up 117%. The headline net loss of -$75.9M is therefore far less alarming than it looks: it is driven by $239M of R&D (61% of revenue) and non-cash charges, not cash burn, so the company is self-funding its AI bet rather than diluting heavily (shares only +3.2%, buybacks essentially nil).

The other side is that GAAP profitability remains unproven. Operating margin is -21.1%, ROE is -12.8%, and the accumulated deficit deepened to -$328M. At $67.01 the market caps the company at $2.93B, or 7.5x trailing sales — a multiple that already credits the growth reacceleration and AI narrative. After a +7.85% single-day move, much of the near-term good news appears in the price. The 10-K's risk language is concrete on the structural fragilities: revenue depends on design wins that are 'not assured,' the model is exposed to US–China tensions (a material end-market and supply-chain risk for a fabless SoC vendor manufacturing through third-party foundries), and customer/end-product concentration means a single program slip can swing results.